These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 7519485)

  • 1. Autoimmune response against the bullous pemphigoid 180 autoantigen.
    Liu Z; Diaz LA; Giudice GJ
    Dermatology; 1994; 189 Suppl 1():34-7. PubMed ID: 7519485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180.
    Liu Z; Diaz LA; Troy JL; Taylor AF; Emery DJ; Fairley JA; Giudice GJ
    J Clin Invest; 1993 Nov; 92(5):2480-8. PubMed ID: 7693763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An animal model of bullous pemphigoid: what can it teach us?
    Giudice GJ; Liu Z; Diaz LA
    Proc Assoc Am Physicians; 1995 Jul; 107(2):237-41. PubMed ID: 8624858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity.
    Döpp R; Schmidt E; Chimanovitch I; Leverkus M; Bröcker EB; Zillikens D
    J Am Acad Dermatol; 2000 Apr; 42(4):577-83. PubMed ID: 10727301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180.
    Zillikens D; Caux F; Mascaro JM; Wesselmann U; Schmidt E; Prost C; Callen JP; Bröcker EB; Diaz LA; Giudice GJ
    J Invest Dermatol; 1999 Jul; 113(1):117-21. PubMed ID: 10417629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New aspects on the pathogenesis of bullous pemphigoid].
    Schmidt E; Bröcker EB; Zillikens D
    Hautarzt; 2000 Sep; 51(9):637-45. PubMed ID: 11057389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A highly sensitive and simple assay for the detection of circulating autoantibodies against full-length bullous pemphigoid antigen 180.
    Schmidt E; Kromminga A; Mimietz S; Leinfelder U; Sitaru C; Bröcker EB; Zillikens D; Zimmermann U
    J Autoimmun; 2002 Jun; 18(4):299-309. PubMed ID: 12144811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain.
    Giudice GJ; Emery DJ; Zelickson BD; Anhalt GJ; Liu Z; Diaz LA
    J Immunol; 1993 Nov; 151(10):5742-50. PubMed ID: 8228259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins.
    Nakatani C; Muramatsu T; Shirai T
    Br J Dermatol; 1998 Sep; 139(3):365-70. PubMed ID: 9767278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary peptides against the major epitope in the NC16A domain of BP180 show no specificity as vaccines to bullous pemphigoid.
    Nie Z; Garrod DR; Chan LS; Hashimoto T
    J Dermatol Sci; 1999 Nov; 21(3):157-64. PubMed ID: 10527376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis.
    Giudice GJ; Wilske KC; Anhalt GJ; Fairley JA; Taylor AF; Emery DJ; Hoffman RG; Diaz LA
    J Invest Dermatol; 1994 Jun; 102(6):878-81. PubMed ID: 7516396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies.
    Zillikens D; Rose PA; Balding SD; Liu Z; Olague-Marchan M; Diaz LA; Giudice GJ
    J Invest Dermatol; 1997 Oct; 109(4):573-9. PubMed ID: 9326393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
    Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
    Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bullous pemphigoid of childhood: autoantibodies target the same epitopes within the NC16A domain of BP180 as autoantibodies in bullous pemphigoid of adulthood.
    Chimanovitch I; Hamm H; Georgi M; Kroiss M; Stolz W; Apitz C; Bröcker EB; Zillikens D
    Arch Dermatol; 2000 Apr; 136(4):527-32. PubMed ID: 10768652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180.
    Perriard J; Jaunin F; Favre B; Büdinger L; Hertl M; Saurat JH; Borradori L
    J Invest Dermatol; 1999 Feb; 112(2):141-7. PubMed ID: 9989787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.
    Zillikens D; Herzele K; Georgi M; Schmidt E; Chimanovitch I; Schumann H; Mascaro JM; Diaz LA; Bruckner-Tuderman L; Bröcker EB; Giudice GJ
    J Invest Dermatol; 1999 Dec; 113(6):947-53. PubMed ID: 10594735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180.
    Mai Y; Nishie W; Izumi K; Shimizu H
    Front Immunol; 2019; 10():1224. PubMed ID: 31191560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230.
    Skaria M; Jaunin F; Hunziker T; Riou S; Schumann H; Bruckner-Tuderman L; Hertl M; Bernard P; Saurat JH; Favre B; Borradori L
    J Invest Dermatol; 2000 May; 114(5):998-1004. PubMed ID: 10771483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180.
    Schmidt E; Skrobek C; Kromminga A; Hashimoto T; Messer G; Bröcker EB; Yancey KB; Zillikens D
    Br J Dermatol; 2001 Nov; 145(5):778-83. PubMed ID: 11736901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgE autoantibodies against the intracellular domain of BP180.
    Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
    Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.